Schrodinger, Inc. (NASDAQ:SDGR - Get Free Report) has earned an average rating of "Hold" from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $20.50.
Several analysts have weighed in on the stock. Wall Street Zen raised shares of Schrodinger from a "strong sell" rating to a "hold" rating in a research note on Saturday, August 8th. Weiss Ratings cut Schrodinger from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Wednesday, August 12th. UBS Group started coverage on Schrodinger in a report on Friday, August 14th. They issued a "neutral" rating and a $19.00 price objective on the stock. Finally, Morgan Stanley lowered their target price on Schrodinger from $19.00 to $17.00 and set an "equal weight" rating for the company in a research note on Thursday, May 14th.
Check Out Our Latest Report on Schrodinger
Schrodinger Stock Performance
SDGR stock opened at $18.77 on Tuesday. The company has a market capitalization of $1.39 billion, a PE ratio of -25.36 and a beta of 1.63. Schrodinger has a one year low of $10.94 and a one year high of $23.02. The company's 50 day moving average price is $16.53 and its two-hundred day moving average price is $13.97.
Schrodinger (NASDAQ:SDGR - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.41) by $0.49. Schrodinger had a negative net margin of 20.98% and a negative return on equity of 16.37%. The company had revenue of $58.89 million during the quarter, compared to analysts' expectations of $47.19 million. During the same quarter in the prior year, the company earned ($0.65) EPS. The firm's revenue was up 7.5% on a year-over-year basis. On average, research analysts predict that Schrodinger will post -1.89 EPS for the current year.
Institutional Trading of Schrodinger
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. purchased a new stake in shares of Schrodinger during the second quarter valued at approximately $170,978,000. Vanguard Group Inc. increased its stake in shares of Schrodinger by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 6,464,426 shares of the company's stock worth $115,584,000 after buying an additional 125,349 shares during the period. Rubric Capital Management LP increased its stake in shares of Schrodinger by 43.8% in the first quarter. Rubric Capital Management LP now owns 6,000,000 shares of the company's stock worth $68,160,000 after buying an additional 1,828,502 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Schrodinger by 12.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,717,890 shares of the company's stock valued at $66,476,000 after buying an additional 414,231 shares during the last quarter. Finally, Amova Asset Management Americas Inc. raised its holdings in Schrodinger by 13.2% during the 1st quarter. Amova Asset Management Americas Inc. now owns 3,190,837 shares of the company's stock valued at $36,248,000 after buying an additional 371,167 shares during the last quarter. Institutional investors own 79.05% of the company's stock.
About Schrodinger
(
Get Free Report)
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Schrodinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.
While Schrodinger currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.